[1] 王青.丙型病毒性肝炎的研究近况[J]. 国际检验医学杂志，2006，27：349-351.
[2] SZABO E，LOTZ G，PASKA C，et al.Viral hepatitis new data on hepatitis C injection[J]. Patholoncol Res，2003，9:215-221.
[3] FRANOIS C，CASTELAIN S，DUVERLIE G，et al.Optimizing the treatment of chronic viral hepatitis C[J]. Expert Rev Gastroenterol Hepatol，2009，3（6）：607-613.
[4] MARCELLIN P，LAU GK，ZEUZEM S，et al. Comparing the safety，tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peg-interferon alpha-2a[J]. Liver Int，2008，28（4）：477-485.
[5] KRAUS MR，SCHAFER A，SCHTTKER K，et al. Therapy of interferon-induced depression in chronic hepatitis C with citalopram:a randomized，double-blinded，placebo-controlled study[J]. Gut，2008，57（4）：531-536.
[6] ROBAEYS G，DEBIE J，WICHERS MC，et al. Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeks[J]. World Gastroenterol J，2007，13（43）：5736-5740.
[7] 魏来. 亚太地区丙型肝炎病毒感染的诊断、处理和治疗共识[J]. 临床肝胆病杂志，2007，23：323-327.
[8] SCHAEFER M，ENGE LBRECHT MA，GUT O，et al. Interferon alpha（IFN-alpha）and psychiatric syndromes：a review[J]. Prog Neuropsychopharmacol Biol Psychiatry，2002，26∶731-746.
[9] JONNATHAN EA，GERGE P，DAVID M，et al. S-adenosyl-1-methjonine（SAMe）as an adjunct for resistant major depressive disorder[J]. Clin Psychopharmacol，2004，24（6）：661.
[10] 刘平，顾牛范，翁史旻，等. S-腺苷蛋氨酸治疗抑郁症[J]. 中国心理卫生杂志，1998，12（2）：94.
[11] SCHAEFER M，CHWAIGER M，GARKISCH AS，et al. Prevention of interferon-alpha associated depression in psychiatric risk patient with chronic hepatitis C[J]. Hepatology，2005，42（6）：793-798. |
